Browsing by Author "Andia, Marcelo"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Accelerating dual cardiac phase images using phase encoding trajectories
    (ELSEVIER SCIENCE INC, 2016) Letelier, Karis; Urbina, Jesus; Andia, Marcelo; Tejos, Cristian; Irarrazaval, Pablo; Prieto, Claudia; Uribe, Sergio
    A three-dimensional dual-cardiac-phase (3D-DCP) scan has been proposed to acquire two data sets of the whole heart and great vessels during the end-diastolic and end-systolic cardiac phases in a single free-breathing scan. This method has shown accurate assessment of cardiac anatomy and function but is limited by long acquisition times. This work proposes to accelerate the acquisition and reconstruction of 3D-DCP scans by exploiting redundant information of the outer k-space regions of both cardiac phases. This is achieved using a modified radial-phase-encoding trajectory and gridding reconstruction with uniform coil combination. The end-diastolic acquisition trajectory was angularly shifted with respect to the end-systolic phase. Initially, a fully-sampled 3D-DCP scan was acquired to determine the optimal percentage of the outer k-space data that can be combined between cardiac phases. Thereafter, prospectively undersampled data were reconstructed based on this percentage. As gold standard images, the undersampled data were also reconstructed using iterative SENSE. To validate the method, image quality assessments and a cardiac volume analysis were performed. The proposed method was tested in thirteen healthy volunteers (mean age, 30 years). Prospectively undersampled data (R = 4) reconstructed with 50% combination led high quality images. There were no significant differences in the image quality and in the cardiac volume analysis between our method and iterative SENSE. In addition, the proposed approach reduced the reconstruction time from 40 min to 1 min. In conclusion, the proposed method obtains 3D-DCP scans with an image quality comparable to those reconstructed with iterative SENSE, and within a clinically acceptable reconstruction time. (C) 2016 Elsevier Inc. All rights reserved.
  • Thumbnail Image
    Item
    Intake of red wine grape pomace decreased atherosclerosis, attenuated myocardial damage and increased survival in a murine model of lethal coronary heart disease
    (MDPI, 2019) Salas Perez, Francisca Lorena; Rivera Vega, Katherine Solange; Echeverria, Guadalupe; Urquiaga, Ines; Dicenta, Sara; Perez, Druso; Andia, Marcelo; Uribe, Sergio; Tejos, Cristian; Busso, Dolores; Irarrazaval Mena, Pablo; Rigotti, Attilio
  • Thumbnail Image
    Item
    Oncological benefit versus cardiovascular risk in breast cancer patients treated with modern radiotherapy
    (2022) Acevedo, Francisco; Ip, Teresa; Orellana, María; Martínez, Gonzalo; Gabrielli, Luigi; Andia, Marcelo; Besa, Cecilia; Pinto, Mauricio P.; Sánchez, Cesar; Merino, Tomas
    Radiotherapy (RT) is an essential part of breast cancer (BC) treatments. Unfortunately, heart exposure to radiation can also impair the long-term survival of patients. Our study aimed to quantify the oncological benefit and the cardiovascular (CV) risk associated with modern RT in a real-world cohort of BC patients. Our descriptive study enrolled BC patients who received adjuvant RT. Ten-year overall survival (OS) was estimated using Predict® version 2.1 (National Health Service, London, UK). The basal risk of CV events was estimated using the American Heart Association (ACC/AHA) CV score. Treatment volumes and mean cardiac doses were obtained from RT treatment plan records. The increased risk of CV events due to RT was estimated using a model proposed by Darby. The risk of acute myocardial infarction or stroke mortality was estimated using HeartScore® (European Society of Cardiology, Brussels, Belgium). A total of 256 BC patients were included in the study. The average age of patients was 57 years old (range: 25–91); 49.6% had left BC. The mean cardiac dose was 166 cGy (interquartile range (IQR) 94–273); the estimated hazard ratio (HR) for CV disease was HR 1.12 (confidence interval (CI) 1.04–1.24). The estimated baseline 10-year CV risk was 5.6% (0.2 to 51.2); CV risk increased by 0.9% (range 0.02–35.47%) after RT. The absolute risk of 10-year mortality from CV disease was 2.5% (0.1–9); RT was associated with an estimated 4.9% survival benefit (3.73–6.07) against BC death and a 0.23% (0.17–0.29) estimated increase in CV mortality. Modern RT decreased 10-year BC mortality by 4% but increased CV mortality by 0.2% in this cohort. Our findings encourage the implementation of personalized adjuvant RT treatments that balance risks and benefits to improve long-term BC patient survival.